Psoriasis Associated With Increased Risk of Diabetes Mellitus

Published Online: Thursday, August 16, 2012
Follow Pharmacy_Times:
Patients who have the chronic autoimmune condition psoriasis may be at increased risk of developing diabetes mellitus (DM), according to a study published online in June 2012 in Archives of Dermatology.

The researchers collected data on 108,132 patients with psoriasis listed in the British Health Improvement Network and compared them with 430,716 patients without the disorder. Their results showed that those with mild psoriasis were 11% more likely and those with severe psoriasis were 46% more likely to develop DM compared with those in the control group.

The authors hypothesized that the relationship between the 2 conditions is that they are both driven by chronic inflammation. They also noted that several prior studies have found evidence of endogenous insulin resistance in psoriasis patients.

“These findings, combined with the large literature linking psoriasis to cardiovascular and metabolic disease, suggest that patients with psoriasis should be encouraged to lower their risk of DM and its complications by undergoing therapeutic lifestyle changes and appropriate screenings for signs of insulin resistance,” the authors wrote.

To read more articles in this watch, click:
Psoriasis Associated With Increased Risk of Diabetes Mellitus
Diabetes Drug Shown to Prompt New Cell Growth

 



Related Articles
Excess medical costs for diabetes and lost productivity amounted to more than $322 billion in 2012, a 48% increase from the $218 billion estimate for 2007.
A long-term study of Celgene Corporation’s apremilast showed that the oral selective inhibitor of phosphodiesterase 4 provides relief to adult patients with active psoriatic arthritis, as well as adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy.
Patients with type 2 diabetes mellitus may see a reduction in blood sugar levels and body weight with empagliflozin treatment, according to data from Eli Lilly and Company and Boehringer Ingelheim Pharmaceuticals Inc.
Latest Issues
$auto_registration$